Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.7 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |